<DOC>
	<DOCNO>NCT00627406</DOCNO>
	<brief_summary>The purpose study possibly improve clinical outcome explore incidence OHSS patient , final oocyte maturation GnRHa ( Buserelin ) GnRH antagonist IVF/ICSI cycle</brief_summary>
	<brief_title>Triggering Final Oocyte Maturation With GnRHa ( Buserelin ) GnRH Antagonist Cycles</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Buserelin</mesh_term>
	<criteria>Patient comply condition IVF ICSI treatment Female age 20 year 40 year Normal regular cycle patient oligomenorrhea BMI &gt; 18 &lt; 35 patient contribute one cycle Significant disturbances woman ( diabetes , epilepsy , liver/renal/heart disease , metabolic disorder ) Patients &gt; 25 follicle day trigger ovulation</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>GnRH antagonist</keyword>
	<keyword>GnRH agonist</keyword>
	<keyword>hCG</keyword>
	<keyword>OHSS</keyword>
	<keyword>In vitro fertilization</keyword>
	<keyword>ovulation induction</keyword>
	<keyword>Clinical pregnancy rate</keyword>
</DOC>